Translate 
Abstract
Background and objectives: In this study, extracts from eight herbal medicines Withania somnifera, Nardostachys jatamansi, Convolvulus pluricaulis, Mucuna pruriens, Centella asiatica, Bacopa monnieri, Tinospora cordifolia, and Ginkgo biloba were combined to create a potential medication. Methods: Quality Control study had been done according guideline or procedure drafted by CCRAS, Ministry of AYUSH, Govt. of India, Oral Acute and Repeated Dose 28-day Toxicity Study had been done according to OECD 423 and 407 guidelines. Results: The polyherbal formulation's physiochemical characteristics, phytochemical content, safety profile, and possible impacts on physiological parameters were all carefully assessed. The formulation was establish to be safe at a single administration dose of 2000 mg/kg and safe at repeated doses up to 1000 mg/kg over the course of 28 days. Conclusion: This study highlights the polyherbal formulation's potential for therapeutic application in the cure of Parkinson's disease by offering insightful information on its toxicological properties and quality control.
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
